The Therapeutic Goods Administration has cleared the Pfizer CCP virus vaccine for elderly patients, despite 30 out of 40,000 elderly people in Norway dying after receiving it.
“The deaths were recorded among very frail patients, including some who were anticipated to only have weeks or months to live,” TGA said in a release on Feb. 2.
